Diagnostic Imaging (DI) Market Size, Share, Trends and Analysis by Product Type, Region and Segment Forecast to 2033
Powered by
Access in-depth insight and stay ahead of the market
Accessing the in-depth insights from the ‘Diagnostic Imaging’ market report can help you:
- Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments.
- Identify competitors’ capabilities to stay ahead in the market.
- Identify segments and get an understanding of various stakeholders.
- Anticipate changes in demand and adjust business development strategies.
- Identify potential regions and countries for growth opportunities.
How is our ‘Diagnostic Imaging’ market report different from other reports in the market?
- The report presents in-depth market sizing and forecasts at a segment level for more than 15 countries, including historical and forecast analysis for 2021-2033 for market assessment.
- Detailed segmentation by:
-
- Product – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents
- Region – North America, Europe, Asia-Pacific, South & Central America, and Middle East & Africa
- The report covers the key market drivers and challenges impacting the diagnostic imaging market.
- The competitive landscape includes an overview and company share analysis by segment in the diagnostic imaging market that will help the stakeholders in the ongoing process of identifying, researching, and evaluating competitors, to gain insight to form their business strategies.
- Competitive profiling and benchmarking of key companies in the market to provide a deeper understanding of industry competition.
We recommend this valuable source of information to anyone involved in:
- Companies Offering Diagnostic Imaging Solutions
- Consulting & Professional Services Firms
- Researchers and Academics
- Venture Capital/Equity Firms
To Get a Snapshot of the Diagnostic Imaging Market Report, Download a Free Sample
Diagnostic Imaging Market Report Overview
The global diagnostic imaging market will be valued at $36.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% over the forecast period. The market growth can be attributed to the rising prevalence of chronic diseases such as cancer and cardiovascular diseases, thereby increasing the demand for sophisticated diagnostic imaging technologies.
The diagnostic imaging market encompasses a wide range of medical devices and systems used for visualizing the internal structures and functions of the human body, aiding in the diagnosis, and monitoring of various medical conditions. This market’s products include X-ray machines, MRI (Magnetic Resonance Imaging) scanners, CT (Computed Tomography) scanners, ultrasound systems, nuclear medicine equipment, and others.
The market holds immense significance in the field of healthcare and medicine, as it plays a pivotal role in the diagnosis and treatment of a wide range of medical conditions. Diagnostic imaging provides essential information for treatment planning. Moreover, surgeons and other healthcare professionals rely on imaging results to understand the size, location, and extent of tumors or abnormalities, aiding in surgical precision and targeted therapies. Its importance extends across several dimensions, impacting patient care, medical research, and healthcare systems.
Diagnostic Imaging Market Outlook, 2021-2033
Buy the Full Report for Additional Insights on Diagnostic Imaging Market Forecast
Diagnostic imaging techniques are largely non-invasive, reducing the need for exploratory surgeries and invasive procedures. This minimizes patient discomfort, recovery time, and healthcare costs. The diagnostic imaging market is integral to medical research and advancements. Imaging studies generate vast datasets that contribute to understanding diseases, treatment efficacy, and patient outcomes. This data is crucial for developing new therapies, drugs, and medical technologies.
Market Size (2023) | $36.5 billion |
Market Size (2033) | $55.0 billion |
CAGR (2023-2033) | 4.2% |
Forecast Period | 2023-2033 |
Historic Data | 2021-2022 |
Report Scope & Coverage | Industry Overview, Market Dynamics, Regulatory Landscape, Reimbursement Scenario, Revenue Forecast, Regional Analysis, Competitive Landscape, Company Profiles |
Product Type | Angio Suites, Bone Densitometers, C-arms, Computed Tomography (CT) Systems, CT systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents |
Regional Segment | North America, Europe, Asia-Pacific, Central & South America, and Middle East & Africa |
Key Companies | Bayer AG, Canon Inc, Cardinal Health Inc, Fujifilm Holdings Corp, GE Healthcare, Hologic Inc, Koninklijke Philips NV, Neusoft Corp, Shimadzu Corp, and Siemens AG |
Diagnostic Imaging Market Segmentation by Product Type
The DI market by product type is segmented into angio suites, bone densitometers, c-arms, CT systems, contrast media injectors, mammography equipment, MRI systems, nuclear imaging equipment, ultrasound systems, x-ray systems, contrast agents, and nuclear imaging agents. The nuclear imaging equipment segment is expected to be the fastest-growing product type segment, with a CAGR of over 7% during the forecast period.
The increasing demand for nuclear imaging equipment in the field of diagnostic imaging represents a significant trend and development in healthcare. Nuclear imaging is a specialized branch of medical imaging that uses radioactive materials or radiopharmaceuticals to visualize and assess the functioning of organs and tissues within the body.
Nuclear imaging techniques such as SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) can help evaluate brain function and detect neurological disorders like Alzheimer’s disease, epilepsy, and brain tumors. Moreover, nuclear imaging often guides minimally invasive procedures, such as radioactive iodine therapy for thyroid cancer or sentinel lymph node mapping in breast cancer surgery.
Diagnostic Imaging Market Share by Product Type, 2023 (%)
Buy the Full Report for Segment-Specific Revenues and Shares
The ultrasound systems segment is leading the market with more than 17% revenue share in 2023. The need for ultrasound systems in the diagnostic imaging market has been consistently increasing due to several key factors and trends. Ultrasound, also known as sonography, is a non-invasive imaging technique that uses high-frequency sound waves to create real-time images of the body’s internal structures.
Ongoing technological advancements have led to the development of more compact, lightweight, and user-friendly ultrasound systems. These innovations have expanded the use of ultrasound across various clinical settings. Ultrasound is a standard tool in obstetrics for monitoring fetal development, assessing fetal health, and diagnosing conditions such as ectopic pregnancies and placental abnormalities. In gynecology, it aids in evaluating reproductive organ health.
Echocardiography, a specialized form of ultrasound, is essential in cardiology for assessing heart structure, function, and blood flow. It is widely used in diagnosing and managing heart conditions, including valvular disorders and congenital heart defects. Ultrasound-guided biopsies are instrumental in diagnosing and staging certain cancers, such as breast cancer and thyroid cancer. Ultrasound also aids in monitoring tumor response to treatment.
Diagnostic Imaging Market Analysis by Region
North America is leading the diagnostic imaging market in terms of revenue in 2023 and is projected to experience a compound annual growth rate of 3.4% over the forecast period. The diagnostic imaging market in North America is one of the most mature markets globally. The region is known for its cutting-edge healthcare technologies, a strong emphasis on research and development, and a commitment to providing high-quality healthcare services.
Prominent companies such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems have a significant presence in the North American market, supplying advanced diagnostic imaging equipment and technologies.
Diagnostic Imaging Market Share by Region, 2023 (%)
Buy the Full Report for Additional Diagnostic Imaging Market Insights
Asia-Pacific accounted for the second highest share in terms of revenue in 2023 in the DI market. The region is projected to witness moderate growth with a CAGR of around 4% over the forecast period from 2023 to 2033. The Asia-Pacific region’s diagnostic imaging market is characterized by its diversity, rapid growth, and commitment to leveraging advanced technologies to improve healthcare outcomes. With its expanding healthcare infrastructure and a growing focus on early disease detection and prevention, APAC plays a pivotal role in shaping the future of diagnostic imaging on a global scale.
The Asia-Pacific region encompasses a wide spectrum of healthcare systems, from highly developed ones in countries like Japan and Singapore to emerging healthcare markets in parts of Southeast Asia. The sheer size and diversity of the population in the Asia-Pacific makes it a critical market for diagnostic imaging. The region faces unique healthcare challenges, including a rapidly aging population and the burden of non-communicable diseases.
The DI market in China has been gaining significant momentum in recent years. China’s diagnostic imaging market reflects its commitment to enhancing healthcare services, advancing technology, and improving patient care. With its vast healthcare infrastructure, innovative capabilities, and a focus on preventive healthcare, China is poised to continue its significant influence on the global diagnostic imaging landscape.
Diagnostic Imaging Market – Competitive Landscape
The global DI market is highly competitive with several key companies offering DI products and services. The diagnostic imaging market is characterized by companies that are continually adapting to changing dynamics. These changes are driven by the rapid advancement of technology, the introduction of novel imaging methods, and an increasing emphasis on precise diagnostic techniques.
As the demand for advanced diagnostic technologies continues to grow, competition intensifies as companies strive to offer cutting-edge imaging solutions, expand their market presence, and address evolving healthcare needs. For instance, the increasing demand for accurate and non-invasive diagnostic solutions has resulted in market leaders, alongside emerging entrants, engage in strategic collaborations, research and development endeavors, and geographic expansion efforts to maintain their competitive edge in the market.
This vibrant marketplace thrives on innovation, accessibility, and a commitment to improving healthcare outcomes through cutting-edge diagnostic imaging technologies. While industry giants dominate the market, emerging players and startups are injecting fresh perspectives and disruptive technologies into the diagnostic imaging landscape. These agile companies often focus on niche areas, exploring novel imaging modalities or pioneering AI applications.
For instance,
- Butterfly Network has developed a handheld, pocket-sized ultrasound device that connects to smartphones, democratizing access to ultrasound imaging. Their innovative approach extends beyond conventional healthcare settings, making diagnostic imaging accessible in remote and resource-limited regions.
- Nanox, an Israeli startup, is revolutionizing X-ray technology by developing a cost-effective, digital X-ray system that promises to make early diagnosis and preventive screening more accessible globally. With its novel approach, Nanox aims to tackle the challenge of limited access in underserved areas.
Leading Companies in the Diagnostic Imaging Market
- Bayer AG
- Canon Inc
- Cardinal Health Inc
- Fujifilm Holdings Corp
- GE Healthcare
- Hologic Inc
- Koninklijke Philips NV
- Neusoft Corp
- Shimadzu Corp
- Siemens AG
Other Diagnostic Imaging Market Vendors Mentioned
Beijing Pharmaceutical Group Co Ltd, Bracco SpA, Diagnostic Medical Systems SA, DuPont de Nemours Inc (Key Subsidiary of Corteva Inc), Guerbet SA, Hitachi Ltd, Nemoto Kyorindo Co Ltd, Novartis AG, Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd), Ulrich GmbH & Co KG and Ziehm Imaging Gmbh
Buy the Full Report to Know More About Leading Diagnostic Imaging Market Players
Diagnostic Imaging Market Segments and Scope
GlobalData Plc has segmented the diagnostic imaging market report by product type and region:
Diagnostic Imaging Market Product Type Outlook (Revenue, $ Million 2021-2033)
- Angio Suites
- Single Plane Angio Suites
- Biplane Angio Suites
- Bone Densitometers
- Dual Energy X-ray Absorptiometry (DEXA)
- Quantitative Ultrasound (QUS)
- C-arms
- Mobile C-arms
- Fixed C-arms
- Computed Tomography (CT) Systems
- 256-320 slice CT Systems
- 128-slice CT Systems
- 64-slice CT Systems
- 20-40 slice CT Systems
- 16-slice and below CT Systems
- Contrast Media Injectors
- Computed Tomography (CT) Injectors
- Magnetic Resonance Imaging (MRI) Injectors
- Angiographic Injectors
- Mammography Equipment
- 2D Digital Mammography Equipment
- Breast Tomosynthesis
- Retrofit Breast Tomosynthesis
- MRI Systems
- 3T MRI Systems
- 5T MRI Systems
- 2T-1.2T MRI Systems
- Nuclear Imaging Equipment
- Positron Emission Tomography (PET) Systems
- Positron Emission Tomography/Computed Tomography (PET/CT) Systems
- Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems
- Single Photon Emission Computed Tomography (SPECT) Systems
- Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems
- Ultrasound Systems
- 2D Ultrasound Systems
- 3D Ultrasound Systems
- Real-Time 3D/4D Ultrasound Systems
- Handheld Ultrasound (HHU) Systems
- X-ray Systems
- Computed Radiography (CR) X-ray Systems
- Direct Digital Radiography (DDR) X-ray Systems
- Contrast Agents
- Computed Tomography (CT) Contrast Agents
- Magnetic Resonance Imaging (MRI) Contrast Agents
- Ultrasound Contrast Agents (Microbubbles)
- Nuclear Imaging Agents
- PET Imaging Agents
- SPECT Imaging Agents
Diagnostic Imaging Market Regional Outlook (Revenue, $ Million, 2021-2033)
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- Netherlands
- Switzerland
- United Kingdom
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Central & South America
- Brazil
- Chile
- Argentina
- Middle East & Africa
- United Arab Emirates
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Scope
- This report provides overview and service addressable market for global Diagnostic Imaging (DI) market
- It identifies the key drivers and restraints impacting growth of the DI market over the next 12 to 24 months.
- It includes global market forecasts for the DI market and reimbursement scenario, and regulatory trends.
- It covers detailed segmentation by product type – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectorst, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents, along with regional segmentation.
Key Highlights
The global Diagnostic Imaging (DI) market will be valued at $36.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% over the forecast period. The diagnostic imaging market’s future is bright, with technology, patient-centric care, and preventive healthcare at the forefront. This industry will continue to play a crucial role in improving healthcare outcomes and advancing medical science. Diagnostic imaging in personalized medicine, helps in tailor treatment plans to individual patient profiles, thereby improving treatment efficacy and reducing adverse effects. AI and machine learning will become integral to diagnostic imaging, automating image analysis and expediting diagnosis, thereby improving workflow efficiency.
Reasons to Buy
- This market intelligence report offers a thorough, forward-looking analysis of the global Diagnostic Imaging (DI) market by product type, regional segments in a concise format to help executives build proactive and profitable growth strategies.
- Accompanying GlobalData’s Forecast products, the report examines the drivers, challenges, and regulatory trend analysis in the DI market.
- Detailed segmentation by product type – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectorst, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents, along with vertical and regional segmentation.
- The report includes 100+ charts and tables providing in-depth analysis of the market size, forecast, and supporting factors which are tailor-made for an executive-level audience, with enhanced presentation quality.
- The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from local market players, which enables executives to quickly get up to speed with the current and emerging trends in DI markets.
- The competitive section of the report helps in identifying the flagbearers, experimenters, contenders, and specialists based on their growth and innovation performance in the DI industry which will help stakeholders analyze competition penetration.
- The broad perspective of the report, coupled with comprehensive, actionable detail, will help DI vendors and other companies succeed in the growing DI market globally.
Key Players
Bayer AGCanon Inc
Cardinal Health Inc
Fujifilm Holdings Corp
GE Healthcare
Hologic Inc
Koninklijke Philips NV
Neusoft Corp
Shimadzu Corp
Siemens AG
Table of Contents
Table
Figures
Frequently asked questions
-
What is the global diagnostic imaging market size in 2023?
The global DI market size will be valued at $36.5 billion in 2023.
-
What is the diagnostic imaging market growth rate?
The global DI market is expected to grow at a CAGR of 4.2% over the forecast period (2023-2033).
-
What is the key DI market driver?
Advancements in imaging technology stand as a prominent driver propelling the growth and transformation of the diagnostic imaging market. Rapid developments in medical imaging techniques, modalities, and equipment are revolutionizing healthcare by enhancing diagnostic accuracy, enabling early disease detection, and facilitating more personalized treatment strategies.
-
What are the key DI market segments?
Product segment – Angio suites, bone densitometers, c-arms, computed tomography (CT) systems, CT systems, contrast media injectors, mammography equipment, MRI systems, nuclear imaging equipment, ultrasound systems, x-ray systems, contrast agents, and nuclear imaging agents.
Regional segment – North America, Europe, Asia-Pacific, South & Central America, and Middle East & Africa
-
Which are the leading DI companies globally?
The leading DI companies are Bayer AG, Canon Inc, Cardinal Health Inc, Fujifilm Holdings Corp, GE Healthcare, Hologic Inc, Koninklijke Philips NV, Neusoft Corp, Shimadzu Corp, and Siemens AG.
-
Is there a third level of segmentation in the report?
GlobalData’s focus is on providing reliable and accurate data that is supported by robust research methodology. Our reports undergo rigorous quality checks and are based on primary and secondary research sources, ensuring that the numbers and insights provided are trustworthy. However, despite the best efforts to gather comprehensive data, there could be instances where the available data is limited, making it challenging to provide third-level segmentation. In such cases, GlobalData may choose to provide high-level insights and general trends rather than forcing segmentation that may not be backed by sufficient data. This approach ensures that the report’s overall quality and credibility are maintained.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.